PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $512,000 | +1.8% | 500,000 | 0.0% | 0.02% | +4.5% |
| Q2 2021 | $503,000 | +2.7% | 500,000 | 0.0% | 0.02% | -4.3% |
| Q1 2021 | $490,000 | +3.4% | 500,000 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $474,000 | +3.0% | 500,000 | 0.0% | 0.02% | -28.1% |
| Q3 2020 | $460,000 | +3.6% | 500,000 | 0.0% | 0.03% | +23.1% |
| Q2 2020 | $444,000 | – | 500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,014,000 | $29,401,000 | 1.13% |
| UBS OCONNOR LLC | 8,000,000 | $7,440,000,000 | 0.15% |
| WHITEBOX ADVISORS LLC | 5,000,000 | $4,727,000 | 0.15% |
| ANGELO GORDON & CO., L.P. | 1,397,000 | $1,321,000 | 0.12% |
| INGALLS & SNYDER LLC | 500,000 | $474,000 | 0.02% |
| CITIGROUP INC | 7,832,000 | $7,404,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |